Hemolysis and schistocytosis in the emergency department: consider pseudothrombotic microangiopathy related to vitamin B12 deficiency.

BACKGROUND Hemolytic anemia with thrombocytopenia and schistocytosis is suggestive of thrombotic thrombocytopenic purpura (TTP). However, these features can occur in the context of vitamin B12 deficiency. AIM To identify simple means of distinguishing between TTP and pseudothrombotic microangiopathies related to vitamin B12 deficiency (pseudo-TMA) at the bedside. DESIGN AND METHODS Retrospective study of patients with pseudo-TMA compared with patients with TTP. The patients with pseudo-TMA were further compared with other cases of cobalamin deficiency, in order to detect factors associated with microangiopathic hemolysis during vitamin B12 deprivation. RESULTS Seven patients with pseudo-TMA were compared with six patients with TTP. The pseudo-TMA patients had higher median lactate dehydrogenase (LDH) levels (7310 vs. 1460 IU/l, P = 0.01), a higher platelet count (73 vs.12.5 × 10(9)/l, P = 0.0023), a lower reticulocyte count (13.1 vs. 265.5 × 10(9)/l, P = 0.0012) and a lower neutrophil count (1.3 vs. 5.1 × 10(9)/l, P = 0.0023). When compared with 21 patients with vitamin B12 deficiency and anemia (but no schistocytosis), the pseudo-TMA patients were more likely to present with pernicious anemia [7 out of 21 (33.3%) vs. 5 out of 7 (71.4%), respectively] and had lower vitamin B12 levels (105 vs. 45 µmol/l, respectively). Vitamin supplementation led to hematological improvements in all pseudo-TMA patients. CONCLUSION In a context of mechanical hemolysis with thrombocytopenia in a patient admitted to the emergency department, very high LDH levels and a low reticulocyte count are strongly suggestive of pseudo-TMA and should prompt the physician to screen for cobalamin deficiency.

[1]  V. Asnafi,et al.  Fragmented red blood cells automated measurement is a useful parameter to exclude schistocytes on the blood film , 2012, International journal of laboratory hematology.

[2]  F. Peyvandi,et al.  Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies , 2012, British journal of haematology.

[3]  M. Radhi,et al.  Thrombotic Microangiopathies , 2012, ISRN hematology.

[4]  J. Mira,et al.  Causes and risk factors of death in patients with thrombotic microangiopathies , 2012, Intensive Care Medicine.

[5]  Eric Rondeau,et al.  Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience , 2011, Haematologica.

[6]  E. Andrès,et al.  Pseudo-thrombotic microangiopathy related to cobalamin deficiency. , 2006, The American journal of medicine.

[7]  Jingxuan Liu,et al.  Bilateral adrenal adenomas and persistent leukocytosis: a unique case of Cushing's syndrome. , 2006, The American journal of medicine.

[8]  E. Andrès,et al.  Current hematological findings in cobalamin deficiency. A study of 201 consecutive patients with documented cobalamin deficiency. , 2006, Clinical and laboratory haematology.

[9]  E. Andrès,et al.  Food-cobalamin malabsorption in elderly patients: clinical manifestations and treatment. , 2005, The American journal of medicine.

[10]  B. Guidet,et al.  Schizocytosis in pernicious anemia mimicking thrombotic thrombocytopenic purpura. , 2003, The American journal of medicine.

[11]  S. Stabler Clinical practice. Vitamin B12 deficiency. , 1996, The New England journal of medicine.

[12]  P. Wilson,et al.  Prevalence of cobalamin deficiency in the Framingham elderly population. , 1994, The American journal of clinical nutrition.

[13]  Toshiyuki Yamamoto,et al.  CONFLICT OF INTEREST: None declared. , 2013 .